Dorien A. Maas
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Procognitive effects of methyl 2-amino-3-methoxybenzoate (or daopine) may involve the dorsal striatal anthranilic acid pathway and mutimetabolite-multitarget pharmacology.
Journal: Behavioural pharmacology
Published: July 01, 2025
Multiscale network neuroscience in neuro-oncology: How tumors, brain networks, and behavior connect across scales.
Journal: Neuro-oncology practice
Published: November 29, 2023
Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia.
Journal: International journal of molecular sciences
Published: March 27, 2023
The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models.
Journal: Current neuropharmacology
Published: October 13, 2022
Antioxidant treatment ameliorates prefrontal hypomyelination and cognitive deficits in a rat model of schizophrenia.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 14, 2020
Key role for lipids in cognitive symptoms of schizophrenia.
Journal: Translational psychiatry
Published: February 17, 2020
Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia.
Journal: Nature communications
Published: May 06, 2019
Aggressive behavior in transgenic animal models: A systematic review.
Journal: Neuroscience and biobehavioral reviews
Published: March 14, 2017
Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia.
Journal: Translational psychiatry
Published: February 01, 2017
Increased GABAB receptor signaling in a rat model for schizophrenia.
Journal: Scientific reports
Published: November 11, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026